These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35662644)

  • 1. Immunological Effects of Anti‒IL-17/12/23 Therapy in Patients with Psoriasis Complicated by Candida Infections.
    Bruno M; Davidson L; Koenen HJPM; van den Reek JMPA; van Cranenbroek B; de Jong EMGJ; van de Veerdonk FL; Kullberg BJ; Netea MG
    J Invest Dermatol; 2022 Nov; 142(11):2929-2939.e8. PubMed ID: 35662644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis.
    Tsiogkas SG; Mavropoulos A; Dardiotis E; Zafiriou E; Bogdanos DP
    Clin Exp Immunol; 2022 Oct; 210(1):79-89. PubMed ID: 35925616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS).
    Marcombes C; Penso L; Weill A; Dray-Spira R; Zureik M; Sbidian E
    Br J Dermatol; 2023 Oct; 189(5):561-568. PubMed ID: 37479503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
    Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
    J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients.
    Furiati SC; Catarino JS; Silva MV; Silva RF; Estevam RB; Teodoro RB; Pereira SL; Ataide M; Rodrigues V; Rodrigues DBR
    Sci Rep; 2019 May; 9(1):7526. PubMed ID: 31101850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
    Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
    Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis.
    Michalak-Stoma A; Bartosińska J; Raczkiewicz D; Kowal M; Kozak J; Gujski M; Krasowska D; Chodorowska G
    Med Sci Monit; 2022 Nov; 28():e938277. PubMed ID: 36419330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis.
    Andersen CSB; Kvist-Hansen A; Siewertsen M; Enevold C; Hansen PR; Kaur-Knudsen D; Zachariae C; Nielsen CH; Loft N; Skov L
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis.
    Rosati D; Bruno M; Jaeger M; Kullberg BJ; van de Veerdonk F; Netea MG; Ten Oever J
    J Infect Dis; 2022 May; 225(10):1796-1806. PubMed ID: 32702099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.
    Eyerich K; Foerster S; Rombold S; Seidl HP; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
    J Invest Dermatol; 2008 Nov; 128(11):2640-2645. PubMed ID: 18615114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System.
    Penso L; Bergqvist C; Meyer A; Herlemont P; Weill A; Zureik M; Dray-Spira R; Sbidian E
    Arthritis Rheumatol; 2022 Feb; 74(2):244-252. PubMed ID: 34279061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils.
    Romani L; Bistoni F; Puccetti P
    Chem Immunol; 1997; 68():110-35. PubMed ID: 9329219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors.
    Kridin K; Schonmann Y; Solomon A; Damiani G; Tzur Bitan D; Onn E; Weinstein O; Cohen AD
    J Dermatolog Treat; 2022 Jun; 33(4):2014-2020. PubMed ID: 33759683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
    Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
    Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking interleukin-17 in psoriasis: Real-world experience from the PsoPlus cohort.
    Schots L; Soenen R; Blanquart B; Thomas D; Lambert J
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):698-710. PubMed ID: 36562700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources.
    Davidson L; van den Reek JMPA; Bruno M; van Hunsel F; Herings RMC; Matzaraki V; Boahen CK; Kumar V; Groenewoud HMM; van de Veerdonk FL; Netea MG; de Jong EMGJ; Kullberg BJ
    Lancet Reg Health Eur; 2022 Feb; 13():100266. PubMed ID: 34950923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors.
    Koike Y; Kuwatsuka S; Nishimoto K; Motooka D; Murota H
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro.
    Said A; Bock S; Müller G; Weindl G
    Immunology; 2015 Feb; 144(2):218-30. PubMed ID: 25059418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors - A population-based study.
    Kridin K; Zirpel H; Mruwat N; Ludwig RJ; Thaci D
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2319-2326. PubMed ID: 37466275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.